Selected article for: "epithelial cell and human epithelial cell"

Author: Im, Kyungtaek; Kim, Jisu; Min, Hyeyoung
Title: Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection
  • Document date: 2015_9_16
  • ID: u800148j_8
    Snippet: In addition, RGE protected human epithelial cells from RSVinduced cell death and viral replication and inhibited the production of proinflammatory cytokines in vitro upon RSV infection [20, 21] . Moreover, RGE treatment improved clinical outcomes by preventing weight loss and increasing viral clearance and IFN-g production in bronchoalveolar lavage cells in mice [20, 21] . RGE also increased the numbers of CD11cþ dendritic cells, IFN-g-secreting.....
    Document: In addition, RGE protected human epithelial cells from RSVinduced cell death and viral replication and inhibited the production of proinflammatory cytokines in vitro upon RSV infection [20, 21] . Moreover, RGE treatment improved clinical outcomes by preventing weight loss and increasing viral clearance and IFN-g production in bronchoalveolar lavage cells in mice [20, 21] . RGE also increased the numbers of CD11cþ dendritic cells, IFN-g-secreting CD8þ T cells, and CD4þ T cells in bronchoalveolar lavage fluids [20, 21] . Taken together, these studies demonstrate that ginseng has immunomodulatory and antiviral effects against RSV infection through multiple mechanisms, and further studies are required to elucidate the underlying immunoregulatory and antiviral mechanisms at the molecular level.

    Search related documents:
    Co phrase search for related documents
    • antiviral immunomodulatory and cell death: 1, 2, 3, 4, 5
    • antiviral immunomodulatory and clinical outcome: 1, 2, 3, 4
    • antiviral immunomodulatory and epithelial cell: 1, 2, 3
    • antiviral immunomodulatory and human epithelial cell: 1
    • antiviral immunomodulatory and lavage fluid: 1
    • antiviral immunomodulatory and proinflammatory cytokine: 1, 2
    • antiviral immunomodulatory and RSV infection: 1
    • antiviral immunomodulatory and viral clearance: 1, 2, 3, 4
    • antiviral immunomodulatory and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • antiviral immunomodulatory and weight loss: 1, 2, 3
    • antiviral immunoregulatory and clinical outcome: 1
    • bronchoalveolar lavage cell and cell death: 1
    • bronchoalveolar lavage cell and epithelial cell: 1, 2, 3
    • bronchoalveolar lavage cell and human epithelial cell: 1
    • bronchoalveolar lavage cell and lavage cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • bronchoalveolar lavage cell and lavage fluid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
    • bronchoalveolar lavage cell and molecular level: 1
    • bronchoalveolar lavage cell and RSV infection: 1
    • bronchoalveolar lavage cell and viral clearance: 1, 2, 3, 4